Jose M. Cotrina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jose M. Cotrina has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Julio Elías Abugattas-Saba
Instituto Nacional de Enfermedades Neoplasicas 2 , Lima, Peru
21 shared publications - Carlos A. Castaneda
Instituto Nacional de Enfermedades Neoplasicas 2 , Lima, Peru
20 shared publications - Marco Galvez-Nino
Instituto Nacional de Enfermedades Neoplasicas 2 , Lima, Peru
20 shared publications - Sandro Casavilca-Zambrano
Department of Pathology, Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Peru
20 shared publications - Silvia Patricia Neciosup
Instituto Nacional de Enfermedades Neoplasicas 2 , Lima, Peru
19 shared publications - Tatiana Vidaurre
Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru
19 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR) in Cancer Research Communications
- Vol. 6 (10) , 2360-2370
Breast Cancer–Protective Genetic Variant Common in Women of Indigenous American Genetic Ancestry Is a cis-eQTL for RMND1 , ARMT1 , and CCDC170 in HER2-Enriched Tumor Subtypes
Breast cancer genome-wide association studies in Hispanic/Latina women in the United States and Latin America have identified independent risk variants in the 6q25 region, including the protective variant rs140068132, located upstream of the estrogen receptor 1 (ESR1) gene. The molecular mechanisms linking this and other variants to breast cancer risk remain poorly understood. To investigate the potential functional role of rs140068132, we analyzed the association between this variant and gene expression in breast cancer tissue. We performed RNA sequencing on 270 tumors from the Peruvian Genomics of Breast Cancer Study and determined intrinsic tumor subtypes using PAM50. The effect of rs140068132 on gene expression across tumor subtypes was assessed using models adjusted for age at diagnosis, Indigenous American genetic ancestry, PAM50 subtype, and an interaction term between tumor subtype and SNP genotype. Subtype-specific effects of the protective rs140068132-G allele were observed in HER2-enriched tumors, with increased expression of ARMT1, RMND1, and CCDC170. These results suggest that in breast cancer tissue from Peruvian patients, rs140068132 influences the expression of multiple genes in a subtype-specific manner, likely acting through a regulatory element at 6q25 that modulates gene expression in cis depending on cellular context. Significance: A protective germline variant, common in women of Indigenous American ancestry, upregulates the expression of cis-genes only in HER2-enriched tumors, providing valuable information for model selection in downstream mechanistic studies.
- 1 October 2026
- Published by American Association for Cancer Research (AACR) in Cancer Research Communications
- Vol. 6 (10) , 2360-2370
Open AccessBreast Cancer–Protective Genetic Variant Common in Women of Indigenous American Genetic Ancestry Is a cis-eQTL for RMND1 , ARMT1 , and CCDC170 in HER2-Enriched Tumor Subtypes
Breast cancer genome-wide association studies in Hispanic/Latina women in the United States and Latin America have identified independent risk variants in the 6q25 region, including the protective variant rs140068132, located upstream of the estrogen receptor 1 (ESR1) gene. The molecular mechanisms linking this and other variants to breast cancer risk remain poorly understood. To investigate the potential functional role of rs140068132, we analyzed the association between this variant and gene expression in breast cancer tissue. We performed RNA sequencing on 270 tumors from the Peruvian Genomics of Breast Cancer Study and determined intrinsic tumor subtypes using PAM50. The effect of rs140068132 on gene expression across tumor subtypes was assessed using models adjusted for age at diagnosis, Indigenous American genetic ancestry, PAM50 subtype, and an interaction term between tumor subtype and SNP genotype. Subtype-specific effects of the protective rs140068132-G allele were observed in HER2-enriched tumors, with increased expression of ARMT1, RMND1, and CCDC170. These results suggest that in breast cancer tissue from Peruvian patients, rs140068132 influences the expression of multiple genes in a subtype-specific manner, likely acting through a regulatory element at 6q25 that modulates gene expression in cis depending on cellular context. Significance: A protective germline variant, common in women of Indigenous American ancestry, upregulates the expression of cis-genes only in HER2-enriched tumors, providing valuable information for model selection in downstream mechanistic studies.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Table S4 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Table S4 shows a list of polymorphisms in the PRS panels with association analyses summary statistics from 7 pooled Hispanic/Latino datasets.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S4 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Table S4 shows a list of polymorphisms in the PRS panels with association analyses summary statistics from 7 pooled Hispanic/Latino datasets.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S1 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Figure S1 shows global ancestry distribution of individuals by countries across seven studies included in this analysis.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S1 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Figure S1 shows global ancestry distribution of individuals by countries across seven studies included in this analysis.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Table S6 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Table S6 shows two-sided Hosmer-Lemeshow P values for calibration of the PRS panels tested in our datasets.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S6 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Table S6 shows two-sided Hosmer-Lemeshow P values for calibration of the PRS panels tested in our datasets.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S4 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Figure S4 shows effect of adding only one H/L SNP to European PRS panels on performance in H/L samples.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S4 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Figure S4 shows effect of adding only one H/L SNP to European PRS panels on performance in H/L samples.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Table S8 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Table S8 shows comparisons of performance of the PRS panel for different pair of ranges of Indigenous American (IA) ancestry.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S8 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Table S8 shows comparisons of performance of the PRS panel for different pair of ranges of Indigenous American (IA) ancestry.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Table S2 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Table S2 shows performance of PRS panels constructed from PRS3820 European panel plus 2 H/L SNPs using different imputation r2 cutoffs.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S2 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Table S2 shows performance of PRS panels constructed from PRS3820 European panel plus 2 H/L SNPs using different imputation r2 cutoffs.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Table S7 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Table S7 shows comparisons of performance for the PRS panel pairs in different ranges of Indigenous American (IA) ancestry.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S7 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Table S7 shows comparisons of performance for the PRS panel pairs in different ranges of Indigenous American (IA) ancestry.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Table S3 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Table S3 shows sample sizes in the Indigenous American ancestry ranges selected for our analysis.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S3 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Table S3 shows sample sizes in the Indigenous American ancestry ranges selected for our analysis.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S2 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Figure S2 shows performance of PRS panels with addition of 2 or 3 H/L SNPs
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S2 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Figure S2 shows performance of PRS panels with addition of 2 or 3 H/L SNPs